Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Spectrum Pharmaceuticals, Inc. (SPPI)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SPPI
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Analysis - Latest Articles
by
most recent
|
most commented
December's Game Plan for Biotech
Dec 1
•
Justin M. Hall
•
4 Comments
Spectrum Pharma: Zevalin Sales Ramp Up
Nov 22
•
Justin M. Hall
•
23 Comments
Spectrum Pharma: CMS Rules in Favor of Zevalin
Nov 3
•
Justin M. Hall
•
6 Comments
Shorts Using Any Bad News They Can to Drive Spectrum Pharma Down
Oct 30
•
VFC's Stock House
•
Comment!
Spectrum Pharmaceuticals Is Worth a Close Watch
Oct 28
•
VFC's Stock House
•
Comment!
Spectrum Pharma: Zevalin Has Blockbuster Potential
Oct 25
•
Justin M. Hall
•
35 Comments
On Small Cap Drug Makers and Volatility
Oct 18
•
Justin M. Hall
•
6 Comments
Movers and Shakers Include Flu Stocks Sinovac and BioCryst Pharma
Oct 14
•
M. E. Garza
•
4 Comments
A Mixed Bag for Traders and Investors in Healthcare
Oct 12
•
M. E. Garza
•
Comment!
Equities: Rally Revives as DJIA Hits Year's Highs
Oct 9
•
Midnight Trader
•
5 Comments
Access Pharma: MuGard, Pipeline Make for Appealing Acquisition Possibilities
Sep 30
•
Mike Havrilla
•
4 Comments
Spectrum Pharmaceuticals: Undervalued and (Now) Oversold
Sep 24
•
Justin M. Hall
•
34 Comments
How Zevalin Is Helping Spectrum
Sep 24
•
Justin M. Hall
•
15 Comments
Spectrum Pharmaceuticals: Despite Share Offering, Still Cheap vs. Other Cancer Drugmakers
Sep 20
•
Justin M. Hall
•
3 Comments
Spectrum Pharma: Market Opportunities for Zevalin May Expand Significantly
Sep 13
•
M. E. Garza
•
4 Comments
Spectrum Pharma: Post-Zevalin Approval Sales Should Ramp Up
Sep 11
•
Justin M. Hall
•
23 Comments
Bayer's Bold New Bet Fails to Rain on Spectrum Pharma
Sep 4
•
Michael Becker
•
10 Comments
Spectrum Pharmaceuticals, Sequenom Shares Rise on Heavy Volume
Sep 1
•
M. E. Garza
•
4 Comments
Five Drug Makers with Pending Catalysts
Sep 1
•
Justin M. Hall
•
46 Comments
Monday Options Recap
Aug 31
•
Frederic Ruffy
•
Comment!
Options Trader: August Retrospective
Aug 29
•
Philip Davis
•
Comment!
'Lucky 13 Portfolio': Fuel Systems and Three Cancer Drug Makers
Aug 25
•
Justin M. Hall
•
5 Comments
Spectrum Pharma: Expect a Positive FDA Decision
Aug 23
•
BioPharma Investor
•
9 Comments
Spectrum Pharmaceuticals: The Labor Day Catalyst
Aug 20
•
Justin M. Hall
•
18 Comments
Spectrum Pharmaceuticals: Rumors of Buyout Talks Persist
Aug 10
•
Justin M. Hall
•
24 Comments
Friday Options Recap
Aug 7
•
Frederic Ruffy
•
2 Comments
More Positive Developments for Spectrum Pharma
Aug 6
•
M. E. Garza
•
2 Comments
Who Will Buy Spectrum Pharmacueticals?
Aug 6
•
Mark Cifra
•
2 Comments
These Small Cap Cancer Drugmakers Have Big Growth Potential
Aug 4
•
Justin M. Hall
•
24 Comments
Spectrum Pharmaceuticals: Potential Acquisition Target
Aug 2
•
Justin M. Hall
•
4 Comments
Ariad Pharmaceuticals: Advancing in Front of Phase 3 Interim Results
Jul 29
•
Justin M. Hall
•
8 Comments
Spectrum Pharmaceuticals: Outlook Remains Very Promising
Jul 27
•
Justin M. Hall
•
20 Comments
FDA Calendar: 2H09 Binary Event Trades
Jul 27
•
Mike Havrilla
•
3 Comments
FDA Calendar Updates: STAAR Surgical, Spectrum Pharma, Allergan, Incyte, Ardea
Jul 21
•
Mike Havrilla
•
Comment!
Key Developments for Spectrum Pharma, Human Genome Sciences and Hemispherx Biopharma
Jul 21
•
M. E. Garza
•
6 Comments
FDA Calendar Updates: Spectrum, Labopharm, Human Genome Sciences, Orexigen, Trinity
Jul 20
•
Mike Havrilla
•
1 Comment
The 'Micropsia' Group: 8 Healthcare Stocks Bullish in Some Time Frame
Jul 20
•
David M. Gordon
•
Comment!
Spectrum Pharmaceuticals and Zevalin: The Importance of FDA Approval
Jul 19
•
Justin M. Hall
•
2 Comments
Access Pharma: Deep Pipeline, Shallow Valuation
Jul 15
•
Mike Havrilla
•
2 Comments
Spectrum Pharmaceuticals: Oversold and Undervalued
Jul 14
•
Justin M. Hall
•
10 Comments
FDA Calendar Updates: Rigel Pharma, GlaxoSmithKline, Eisai, SuperGen
Jul 9
•
Mike Havrilla
•
Comment!
1
2
Next Page